Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2008 May 7;64(Pt 6):o1010–o1011. doi: 10.1107/S1600536808012555

1-De­oxy-d-arabinitol

Sarah F Jenkinson a,*, Filipa P Cruz a, Kathrine V Booth a, George W J Fleet a, Ken Izumori b, Chu-Yi Yu c, David J Watkin d
PMCID: PMC2961547  PMID: 21202536

Abstract

Addition of methyl lithium to d-erythrono-1,4-lactone followed by acid deprotection was shown, by X-ray crystallography, to give 1-de­oxy-d-arabinitol, C5H12O4, rather than 1-de­oxy-d-ribitol as the major product. The crystal structure exists as hydrogen-bonded chains of mol­ecules running parallel to the c axis which are further linked together by hydrogen bonds. Each mol­ecule is a donor and an acceptor for four hydrogen bonds.

Related literature

For related literature see: Izumori (2002, 2006); Granstrom et al. (2004); Beadle et al. (1992); Skytte (2002); Levin (2002); Howling & Callagan (2000); Bertelsen et al. (1999); Takata et al. (2005); Menavuvu et al. (2006); Sui et al. (2005); Hossain et al. (2006); Zehner et al. (1994); Donner et al. (1999); Yoshihara et al. (2008); Takai & Heathcock (1985); Zissis & Richtmyer (1954).graphic file with name e-64-o1010-scheme1.jpg

Experimental

Crystal data

  • C5H12O4

  • M r = 136.15

  • Tetragonal, Inline graphic

  • a = 12.9873 (5) Å

  • c = 8.3679 (3) Å

  • V = 1411.41 (9) Å3

  • Z = 8

  • Mo Kα radiation

  • μ = 0.11 mm−1

  • T = 150 K

  • 0.25 × 0.25 × 0.25 mm

Data collection

  • Nonius KappaCCD area-detector diffractometer

  • Absorption correction: multi-scan (DENZO/SCALEPACK; Otwinowski & Minor, 1997) T min = 0.93, T max = 0.97

  • 3189 measured reflections

  • 855 independent reflections

  • 750 reflections with I > 2σ(I)

  • R int = 0.020

Refinement

  • R[F 2 > 2σ(F 2)] = 0.043

  • wR(F 2) = 0.123

  • S = 1.00

  • 855 reflections

  • 82 parameters

  • 1 restraint

  • H-atom parameters constrained

  • Δρmax = 0.34 e Å−3

  • Δρmin = −0.39 e Å−3

Data collection: COLLECT (Nonius, 2001); cell refinement: DENZO/SCALEPACK (Otwinowski & Minor, 1997); data reduction: DENZO/SCALEPACK; program(s) used to solve structure: SIR92 (Altomare et al., 1994); program(s) used to refine structure: CRYSTALS (Betteridge et al., 2003); molecular graphics: CAMERON (Watkin et al., 1996); software used to prepare material for publication: CRYSTALS.

Supplementary Material

Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808012555/lh2622sup1.cif

e-64-o1010-sup1.cif (12.9KB, cif)

Structure factors: contains datablocks I. DOI: 10.1107/S1600536808012555/lh2622Isup2.hkl

e-64-o1010-Isup2.hkl (43.2KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
O8—H8⋯O8i 0.96 1.76 2.698 (4) 164
O6—H6⋯O6ii 1.00 1.98 2.712 (4) 128
O4—H4⋯O1iii 0.98 1.77 2.718 (4) 162
O1—H1⋯O4iv 1.05 2.03 2.712 (3) 120

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic.

supplementary crystallographic information

Comment

The demand for the large scale production of rare sugars by biotechnological (Izumori, 2006; Izumori, 2002; Granstrom et al., 2004) and chemical (Beadle et al., 1992) methods is driven by the demand for alternative foodstuffs (Skytte, 2002) and D-tagatose itself is used as a low calorie sweetener (Levin, 2002; Howling & Callagan, 2000; Bertelsen et al. 1999) Rare monosaccharides have been found to demonstrate interesting pharmaceutical properties, for example, D-psicose (Takata et al., 2005; Menavuvu et al., 2006) and D-allose (Sui et al., 2005; Hossain et al., 2006) have significant chemotherapeutic properties and D-tagatose has been found to be an anti-hyperglycemic agent (Zehner et al., 1994; Donner et al., 1999) and therefore potentially useful in the treatment of diabetes.

The methodology developed by Izumori et al. (2002, 2006) for the interconversion of tetroses, pentoses and hexoses by enzymatic oxidation, inversion at C3 with a single epimerase, and reduction to the aldose has been seen to be generally applicable for the 1-deoxy ketohexoses (Yoshihara et al., 2008). In order to investigate the viability of this process to the corresponding pentoses and thus to evaluate their therapeutic potential 1-deoxy-D-arabinitol was synthesized, in 3 steps, from 2,3-O-isopropylidene-D-erythronolactone 1 (Fig.1). It has previously been seen that the four diastereomeric tetraols are very difficult to distinguish between by NMR spectroscopy (Takai & Heathcock, 1985). X-ray crystallography confirmed that the major product was the arabinitol 4 rather than the ribitol 3 which differs only in the stereochemistry at the C2 position (Fig. 2).

The molecules are linked by three hydrogen bonding systems and the structure consists of alternating spiral chains of O6—H6···O6 or O8—H8···O8 hydrogen-bonded molecules running parallel to the c-axis (Fig. 3) interconnected by O1—H1···O4—H4···O1 hydrogen bonds (Fig.4). Each molecule is a donor and acceptor for 4 hydrogen bonds (Fig. 5).

In summary, the stereochemistry at C2 of the title compound 1-deoxy-D-arabinitol 4 was firmly established by X-ray crystallography, the absolute configuration is determined by the use of D-erythronolactone as the starting material. As well as the potential biological properties of 1-deoxy ketoses, they are likely to provide a new set of building blocks for the synthesis of a wide variety of complex biomolecules.

Experimental

The title compound was recrystallized from hot methanol: m.p. 398–400 K; [α]D21 +0.8 (c, 8 in H2O) {Lit. (Zissis & Richtmyer, 1954) m.p. 129–131°C; [α]D20 +0.7 (c, 10 in H2O; l, 4)}.

Refinement

In the absence of significant anomalous scattering, Friedel pairs were merged and the absolute configuration assigned from the starting material.

The H atoms were all located in a difference map, but those attached to carbon atoms were repositioned geometrically. The H atoms were initially refined with soft restraints on the bond lengths and angles to regularize their geometry (C—H in the range 0.93–0.98, O—H = 0.82 Å) and Uiso(H) (in the range 1.2–1.5 times Ueq of the parent atom), after which the positions were refined with riding constraints.

Figures

Fig. 1.

Fig. 1.

Synthetic scheme.

Fig. 2.

Fig. 2.

The title compound with displacement ellipsoids drawn at the 50% probability level. H atoms are shown as spheres of arbitary radius.

Fig. 3.

Fig. 3.

Packing diagram showing the O6—H6···O6 and O8—H8···O8 hydrogen bonds.

Fig. 4.

Fig. 4.

Packing diagram showing the O1—H1···O4—H4···O1 hydrogen bonds.

Fig. 5.

Fig. 5.

Packing diagram for the compound projected along the c-axis. Each molecule is a donor and an acceptor for 4 hydrogen-bonds.

Crystal data

C5H12O4 Z = 8
Mr = 136.15 F000 = 592
Tetragonal, I41 Dx = 1.281 Mg m3
Hall symbol: I 4bw Mo Kα radiation λ = 0.71073 Å
a = 12.9873 (5) Å Cell parameters from 815 reflections
b = 12.9873 (5) Å θ = 5–27º
c = 8.3679 (3) Å µ = 0.11 mm1
α = 90º T = 150 K
β = 90º Block, colourless
γ = 90º 0.25 × 0.25 × 0.25 mm
V = 1411.41 (9) Å3

Data collection

Nonius KappaCCD area-detector diffractometer 750 reflections with I > 2σ(I)
Monochromator: graphite Rint = 0.020
T = 150 K θmax = 27.5º
ω scans θmin = 5.3º
Absorption correction: multi-scan(DENZO/SCALEPACK; Otwinowski & Minor, 1997) h = −16→16
Tmin = 0.93, Tmax = 0.97 k = −11→11
3189 measured reflections l = −10→10
855 independent reflections

Refinement

Refinement on F2 Primary atom site location: structure-invariant direct methods
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.043 H-atom parameters constrained
wR(F2) = 0.123   w = 1/[σ2(F2) + ( 0.07P)2 + 1.26P], where P = (max(Fo2,0) + 2Fc2)/3
S = 1.00 (Δ/σ)max = 0.002
855 reflections Δρmax = 0.34 e Å3
82 parameters Δρmin = −0.39 e Å3
1 restraint Extinction correction: None

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
O1 0.64776 (13) 0.51955 (15) 0.6622 (3) 0.0211
C2 0.75127 (18) 0.5139 (2) 0.6068 (4) 0.0186
C3 0.7537 (2) 0.4842 (2) 0.4296 (4) 0.0187
O4 0.85700 (13) 0.48073 (16) 0.3723 (3) 0.0237
C5 0.6897 (2) 0.5564 (2) 0.3268 (4) 0.0235
O6 0.73116 (15) 0.65798 (14) 0.3242 (3) 0.0250
C7 0.8135 (2) 0.4417 (2) 0.7135 (4) 0.0208
O8 0.76689 (14) 0.34124 (13) 0.7126 (3) 0.0216
C9 0.8162 (3) 0.4788 (2) 0.8844 (4) 0.0371
H21 0.7853 0.5822 0.6286 0.0184*
H31 0.7208 0.4168 0.4126 0.0196*
H51 0.6985 0.5315 0.2238 0.0277*
H52 0.6191 0.5542 0.3475 0.0271*
H71 0.8827 0.4379 0.6604 0.0259*
H91 0.8413 0.4265 0.9544 0.0541*
H92 0.8595 0.5396 0.8958 0.0548*
H93 0.7474 0.4971 0.9202 0.0552*
H1 0.6194 0.4722 0.5703 0.0308*
H8 0.7975 0.2944 0.6379 0.0334*
H6 0.7418 0.6761 0.4388 0.0359*
H4 0.9070 0.5369 0.3651 0.0365*

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
O1 0.0197 (10) 0.0197 (9) 0.0240 (12) 0.0010 (7) 0.0042 (9) −0.0023 (9)
C2 0.0139 (13) 0.0193 (12) 0.0225 (16) −0.0037 (9) 0.0006 (12) −0.0001 (13)
C3 0.0176 (14) 0.0167 (12) 0.0218 (17) −0.0006 (9) −0.0011 (12) 0.0010 (13)
O4 0.0169 (9) 0.0213 (9) 0.0329 (14) 0.0015 (7) 0.0061 (10) 0.0035 (10)
C5 0.0223 (14) 0.0269 (15) 0.0214 (16) 0.0014 (11) 0.0013 (13) 0.0032 (15)
O6 0.0308 (11) 0.0215 (10) 0.0227 (12) 0.0025 (8) 0.0056 (11) 0.0046 (10)
C7 0.0201 (13) 0.0204 (13) 0.0218 (16) −0.0035 (10) −0.0045 (13) −0.0004 (13)
O8 0.0254 (10) 0.0189 (10) 0.0204 (12) 0.0010 (7) 0.0049 (10) 0.0000 (9)
C9 0.053 (2) 0.0332 (16) 0.0253 (15) −0.0023 (15) −0.0149 (15) −0.0036 (13)

Geometric parameters (Å, °)

O1—C2 1.424 (3) C5—H51 0.927
O1—H1 1.051 C5—H52 0.934
C2—C3 1.532 (3) O6—H6 0.997
C2—C7 1.527 (4) C7—O8 1.438 (3)
C2—H21 1.008 C7—C9 1.510 (5)
C3—O4 1.425 (3) C7—H71 1.004
C3—C5 1.520 (4) O8—H8 0.959
C3—H31 0.985 C9—H91 0.954
O4—H4 0.978 C9—H92 0.974
C5—O6 1.425 (3) C9—H93 0.972
C2—O1—H1 93.6 C3—C5—H52 114.4
O1—C2—C3 110.4 (2) O6—C5—H52 113.8
O1—C2—C7 109.9 (3) H51—C5—H52 106.4
C3—C2—C7 113.6 (2) C5—O6—H6 104.9
O1—C2—H21 108.0 C2—C7—O8 109.4 (2)
C3—C2—H21 112.9 C2—C7—C9 111.7 (2)
C7—C2—H21 101.7 O8—C7—C9 107.7 (3)
C2—C3—O4 110.7 (2) C2—C7—H71 104.2
C2—C3—C5 112.4 (2) O8—C7—H71 109.3
O4—C3—C5 110.1 (2) C9—C7—H71 114.4
C2—C3—H31 110.8 C7—O8—H8 113.9
O4—C3—H31 109.4 C7—C9—H91 111.2
C5—C3—H31 103.2 C7—C9—H92 111.4
C3—O4—H4 128.4 H91—C9—H92 108.7
C3—C5—O6 111.9 (2) C7—C9—H93 110.4
C3—C5—H51 104.0 H91—C9—H93 107.4
O6—C5—H51 105.2 H92—C9—H93 107.6

Hydrogen-bond geometry (Å, °)

D—H···A D—H H···A D···A D—H···A
O8—H8···O8i 0.96 1.76 2.698 (4) 164
O6—H6···O6ii 1.00 1.98 2.712 (4) 128
O4—H4···O1iii 0.98 1.77 2.718 (4) 162
O1—H1···O4iv 1.05 2.03 2.712 (3) 120

Symmetry codes: (i) y+1/2, −x+1, z−1/4; (ii) y, −x+3/2, z+1/4; (iii) −y+3/2, x, z−1/4; (iv) −y+1, x−1/2, z+1/4.

Footnotes

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH2622).

References

  1. Altomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M. C., Polidori, G. & Camalli, M. (1994). J. Appl. Cryst.27, 435.
  2. Beadle, J. R., Saunders, J. P. & Wajda, T. J. (1992). US Patent 5 078 796.
  3. Bertelsen, H., Jensen, B. B. & Buemann, B. (1999). World Rev. Nutr. Diet.85, 98–109. [DOI] [PubMed]
  4. Betteridge, P. W., Carruthers, J. R., Cooper, R. I., Prout, K. & Watkin, D. J. (2003). J. Appl. Cryst.36, 1487.
  5. Donner, T. W., Wilber, J. F. & Ostrowski, D. (1999). Diabetes Obes. Metab.1, 285–291. [DOI] [PubMed]
  6. Granstrom, T. B., Takata, G., Tokuda, M. & Izumori, K. (2004). J. Biosci. Bioeng.97, 89–94. [DOI] [PubMed]
  7. Hossain, M. A., Wakabayashi, H., Izuishi, K., Okano, K., Yachida, S., Tokuda, M., Izumori, K. & Maeta, H. (2006). J. Biosci. Bioeng.101, 369–371. [DOI] [PubMed]
  8. Howling, D. & Callagan, J. L. (2000). PCT Int. App. WO 2000 042 865.
  9. Izumori, K. (2002). Naturwissenschaften, 89, 120–124. [DOI] [PubMed]
  10. Izumori, K. (2006). J. Biotechnol.124, 717–722. [DOI] [PubMed]
  11. Levin, G. V. (2002). J. Med. Food, 5, 23–36. [DOI] [PubMed]
  12. Menavuvu, B. T., Poonperm, W., Leang, K., Noguchi, N., Okada, H., Morimoto, K., Granstrom, T. B., Takada, G. & Izumori, K. (2006). J. Biosci. Bioeng.101, 340–345. [DOI] [PubMed]
  13. Nonius (2001). COLLECT Nonius BV, Delft, The Netherlands.
  14. Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307–326. New York: Academic Press.
  15. Skytte, U. P. (2002). Cereal Foods World47, 224–224.
  16. Sui, L., Dong, Y. Y., Watanabe, Y., Yamaguchi, F., Hatano, N., Tsukamoto, I., Izumori, K. & Tokuda, M. (2005). Intl. J. Ocology, 27, 907-912. [PubMed]
  17. Takai, K. & Heathcock, C. H. (1985). J. Org. Chem.50, 3247–3251.
  18. Takata, M. K., Yamaguchi, F., Nakanose, Y., Watanabe, Y., Hatano, N., Tsukamoto, I., Nagata, M., Izumori, K. & Tokuda, M. (2005). J. Biosci. Bioeng.100, 511–516. [DOI] [PubMed]
  19. Watkin, D. J., Prout, C. K. & Pearce, L. J. (1996). CAMERON Chemical Crystallography Laboratory, Oxford, UK.
  20. Yoshihara, A., Haraguchi, S., Gullapalli, P., Rao, D., Morimoto, K., Takata, G., Jones, N., Jenkinson, S. F., Wormald, M. R., Dwek, R. A., Fleet, G. W. J. & Izumori, K. (2008). Tetrahedron Asymmetry, 19, 1739–745.
  21. Zehner, L. R., Levin, G. V., Saunders, J. P. & Beadle, J. R. (1994). US Patent 5 356 879.
  22. Zissis, E. & Richtmyer, N. K. (1954). J. Am. Chem. Soc.76, 5515–5522.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808012555/lh2622sup1.cif

e-64-o1010-sup1.cif (12.9KB, cif)

Structure factors: contains datablocks I. DOI: 10.1107/S1600536808012555/lh2622Isup2.hkl

e-64-o1010-Isup2.hkl (43.2KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES